ProKidney Corp. Class A share price logo

ProKidney Corp. Class A

NASDAQ: PROK

Small Cap

$1.60

-0.16

(-8.81%)

as on

ProKidney Corp. Class A Stock Performance

as on July 14, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.61
    $1.75
    downward going graph

    -0.63%

    Downside

    9.37%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.53
    $4.95
    downward going graph

    4.38%

    Downside

    209.38%

    Upside

    downward going graph

ProKidney Corp. Class A share price movements today

Previous Close
$1.76
Open
$1.75
Volume
2.2M
Day's Low - High
$1.61 - $1.75
52 Week Low - High
$1.53 - $4.95

ProKidney Corp. Class A Historical Returns

1 Month Return
+ 7.32 %
3 Month Return
-7.85 %
1 Year Return
-52.3 %
3 Year Return
-84.17 %
5 Year Return
0 %

ProKidney Corp. Class A Stock Fundamentals & Key Indicators

Check ProKidney Corp. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$531.6M

EPS (TTM)

-0.5383

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-161.9M

Revenue (TTM)

889.0K

Profit Margin

0.00%

Return On Equity TTM

-49.37%

ProKidney Corp. Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ProKidney Corp. Class A with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
ProKidney Corp. Class A image
ProKidney Corp. Class A
BUY$531.6MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$39.9B75.39%75.2512.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$123.2B145.28%28.8235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$69.7B14.36%16.2429.65%0.54%

Stock Returns calculator for ProKidney Corp. Class A Stock including INR - Dollar returns

The ProKidney Corp. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

ProKidney Corp. Class A investment value today

Current value as on today

₹48,199

Returns

-₹51,801

(-51.8%)

Returns from ProKidney Corp. Class A Stock

-₹56,640 (-56.64%)

Dollar Impact

₹4,839 (+4.84%)

Analyst Recommendation on ProKidney Corp. Class A Stock

Based on 12 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for ProKidney Corp. Class A. Average target price of $6.25

ProKidney Corp. Class A Share Price Target

Get share price movements and forecasts by analysts on ProKidney Corp. Class A.

What analysts predicted

74.4%UPSIDE

Target Price

$6.25

Current Price

$1.6

Analyzed by

12 Analysts

Target

$6.25

ProKidney Corp. Class A target price $6.25, a slight upside of 74.4% compared to current price of $1.6. According to 12 analysts rating.

Indian Investors' Interest in ProKidney Corp. Class A Stock

Search interest for ProKidney Corp. Class A Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

ProKidney Corp. Class A Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
4
-
-
-
0
0
0
0
0
0
Gross Profit
3
0
0
-1
0
0
0
0
-1
-1
Operating Income
-24
-40
-43
-48
-51
-41
-39
-38
-45
-44
EBITDA
-17
-34
-37
-41
-45
-35
-34
-33
-40
-41
Interest Expense
0
0
0
0
0
-
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-18
-35
-38
-43
-46
-37
-36
-35
-42
-42
Income Tax Expense
2
0
0
-2
1
0
0
0
-1
-20
Net Income
-5
-9
-12
-17
-21
-16
-16
-16
-19
-22
Net Profit Margin
-126.86%
0.00%
0.00%
0.00%
-27997.37%
-7275.65%
-7489.59%
-7589.40%
-8547.11%
-9992.92%

ProKidney Corp. Class A Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
0
Gross Profit
-
-1
-3
-3
0
0
Operating Income
-27
-55
-153
-151
-183
-165
EBITDA
-26
-53
-143
-125
-158
-144
Interest Expense
0
0
0
0
0
0
Depreciation
0
1
3
3
5
6
Income Before Tax
-26
-55
-147
-129
-163
-151
Income Tax Expense
0
0
0
5
0
0
Net Income
-26
-55
-108
-35
-61
-68
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-80507.89%
-7725.20%

ProKidney Corp. Class A Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-35
-38
-41
-48
-37
-36
-16
-40
-42
Operating Cash Flow
-34
-38
-29
-24
-29
-31
-26
-32
-41
Investing Cash Flow
58
28
-81
15
28
18
29
28
34
Financing Cash Flow
0
139
4
0
0
0
7
17
0
Change in Cash
23
130
-106
-8
-1
-12
10
13
-6

ProKidney Corp. Class A Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-55
-148
-135
-163
-151
Operating Cash Flow
-25
-50
-77
-90
-126
-120
Investing Cash Flow
-5
-5
-1
-329
20
103
Financing Cash Flow
19
71
548
-9
144
25
Change in Cash
-10
15
469
-429
38
9

Global Institutional Holdings in ProKidney Corp. Class A

Funds
Holdings
BlackRock Inc
0.68%
Bank of America Corp
0.37%
Charles Schwab Investment Management Inc
0.31%
State Street Corp
0.27%
Millennium Management LLC
1.11%
See all

ProKidney Corp. Class A News & Key Events

  • img

    Today's Timeline - 27 August

    Wed, 05:00 PM

    -

    ProKidney announces participation in Citi and Morgan Stanley healthcare conferences in September 2025.

Insights on ProKidney Corp. Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ProKidney Corp. Class A Ordinary Shares has experienced a drawdown of -84.3%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 76.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 17.0% return, outperforming this stock by 78.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PROK stock has moved down by -11.6%

About ProKidney Corp. Class A

ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
OrganisationProKidney Corp. Class A
Headquarters2000 Frontis Plaza Boulevard, Winston-Salem, NC, United States, 27103
IndustryBiotechnology
CEODr. Bruce Culleton M.D.
E-voting on sharesClick here to vote

Key Management of ProKidney Corp. Class A

Name

Title

Mr. Todd C. Girolamo Esq., J.D., M.B.A.

Chief Legal Officer & Secretary

Mr. Kenneth Locke

Chief Technical Officer

Ms. Carla Poulson

Chief People Officer

Dr. Joseph M. Stavas M.D., M.P.H.

SVP of Clinical Affairs

Dr. Darin J. Weber Ph.D.

Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access

Dr. Ulrich Ernst Ph.D.

EVP of Science and Technology

Dr. Bruce Culleton M.D.

CEO & Director

Mr. James Coulston CPA

Chief Financial Officer

Mr. Richard Williams

Chief Information Officer

Dr. Emily Butler Ph.D.

Senior VP of Biometric

FAQs

What is ProKidney Corp. Class A share price today?

ProKidney Corp. Class A share price today is $1.60 as on at the close of the market. ProKidney Corp. Class A share today touched a day high of $1.75 and a low of $1.61.

What is the 52 week high and 52 week low for ProKidney Corp. Class A share?

ProKidney Corp. Class A share touched a 52 week high of $4.95 on and a 52 week low of $1.53 on . ProKidney Corp. Class A stock price today i.e. is closed at $1.60,which is 67.68% down from its 52 week high and 4.58% up from its 52 week low.

What is ProKidney Corp. Class A's market capitalisation today?

ProKidney Corp. Class A market capitalisation is $0.00T as on .

How to invest in ProKidney Corp. Class A Stock (PROK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ProKidney Corp. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ProKidney Corp. Class A Shares that will get you 0.9375 shares as per ProKidney Corp. Class A share price of $1.60 per share as on July 14, 2026 at 1:29 am IST.

What is the minimum amount required to buy ProKidney Corp. Class A Stock (PROK) from India?

Indian investors can start investing in ProKidney Corp. Class A (PROK) shares with as little as ₹95.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.15 in ProKidney Corp. Class A stock (as per the Rupee-Dollar exchange rate as on ). Based on ProKidney Corp. Class A share’s latest price of $1.60 as on July 14, 2026 at 1:29 am IST, you will get 6.2500 shares of ProKidney Corp. Class A. Learn more about fractional shares .